Costunolide (Scheme 7), derived from I. helenium L., demonstrated an antiproliferative effect on various cancer cells and significantly enhanced the antiproliferative efficacy of doxorubicin in drug-resistant cell lines by blocking the PI3K/AKT signaling pathway and reducing P-gp expression [66,67]. The gene discussed is AKT1; the disease is cancer.